trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Body Weight D001835 333 associated lipids
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Cat Diseases D002371 12 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Patel V et al. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. 2009 J. Med. Chem. pmid:19317450
Kee HJ and Kook H Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. 2009 J. Mol. Cell. Cardiol. pmid:19729022
Ong DC et al. LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. 2009 Oncogene pmid:19734946
Alao JP et al. Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay. 2009 Mol. Cancer Ther. pmid:19723888
Noh H et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. 2009 Am. J. Physiol. Renal Physiol. pmid:19553350
Jonsen MD et al. The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain. 2009 Mol. Endocrinol. pmid:19556346
Link PA et al. Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells. 2009 Mol. Cancer Res. pmid:19531572
López-Soto A et al. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. 2009 Oncogene pmid:19430493
Kim W et al. Histone acetyltransferase GCN5 interferes with the miRNA pathway in Arabidopsis. 2009 Cell Res. pmid:19436261
Yoshida M Chemical genomics: a key to the epigenome - an interview with Minoru Yoshida. Interview by Saadi Khochbin. 2009 Int. J. Dev. Biol. pmid:19412886
Kusakabe M et al. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists. 2009 Biochem. Biophys. Res. Commun. pmid:19878646
Halaban R et al. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. 2009 PLoS ONE pmid:19234609
Maalouf WE et al. Trichostatin A treatment of cloned mouse embryos improves constitutive heterochromatin remodeling as well as developmental potential to term. 2009 BMC Dev. Biol. pmid:19210795
Zhang D et al. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism]. 2009 Ai Zheng pmid:19958621
Susick L et al. Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. 2008 Sep-Oct J. Cell. Mol. Med. pmid:18053091
Li X and Bai XZ [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140318
Kir'ianov GI et al. [Nucleosome positioning within neomycinphosphotransferase gene (NPTII) on yeast plasmid in repressed and active state]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140324
Miyoshi M et al. Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. 2008 Nov-Dec Nutrition pmid:18723323
Nishikiori N et al. Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. 2008 May-Jun Jpn. J. Ophthalmol. pmid:18661270
Fenic I et al. In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis. 2008 Mar-Apr J. Androl. pmid:18046049
Smetana K et al. To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. 2008 Jul-Sep Eur J Histochem pmid:18840553
Kovács P and Csaba G The effect of histone deacetylase inhibitor trichostatin A (TSA) on the incorporation of 32P (Pi) and 3H-palmitic acid into the phospholipids of Tetrahymena. 2008 Jan-Feb Cell Biochem. Funct. pmid:17191269
Dowling DP et al. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. 2008 Biochemistry pmid:19053282
Golyshev SA et al. [The role of DNA methylation and histone modifications in structural maintainance of heterochromatin domains (chromocenters)]. 2008 Tsitologiia pmid:19140344
Zhou Q et al. Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells. 2008 Mol. Vis. pmid:19122829
Meng CF et al. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP]. 2008 Ai Zheng pmid:19079988
Khan AN et al. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. 2008 Cancer Immunol. Immunother. pmid:18046553
Domingo-Domènech J et al. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. 2008 Breast Cancer Res. Treat. pmid:18064564
Hajji N et al. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells. 2008 Oncogene pmid:18071312
Walton TJ et al. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. 2008 Prostate pmid:18092350
Arany I et al. Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells. 2008 Am. J. Physiol. Renal Physiol. pmid:18094030
Jiemjit A et al. p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage. 2008 Oncogene pmid:18223691
Wang Q et al. The spatial relationship between heterochromatin protein 1 alpha and histone modifications during mouse oocyte meiosis. 2008 Cell Cycle pmid:18239470
Li X et al. The effects of trichostatin A on mRNA expression of chromatin structure-, DNA methylation-, and development-related genes in cloned mouse blastocysts. 2008 Cloning Stem Cells pmid:18241125
Chou SD and Tomasi TB Spatial distribution of histone methylation during MHC class II expression. 2008 Mol. Immunol. pmid:17850872
Ragno R et al. Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. 2008 Eur J Med Chem pmid:17698257
Byers J and Eichinger D Acetylation of the Entamoeba histone H4 N-terminal domain is influenced by short-chain fatty acids that enter trophozoites in a pH-dependent manner. 2008 Int. J. Parasitol. pmid:17706222
Countryman JK et al. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. 2008 J. Virol. pmid:18337569
Borghol N et al. Transcriptional and epigenetic status of protamine 1 and 2 genes following round spermatids injection into mouse oocytes. 2008 Genomics pmid:18343090
Lin W et al. Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40. 2008 Genes Cells pmid:18298800
Fan J et al. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. 2008 J. Cancer Res. Clin. Oncol. pmid:18264725
Shi LH et al. Trichostatin A (TSA) improves the development of rabbit-rabbit intraspecies cloned embryos, but not rabbit-human interspecies cloned embryos. 2008 Dev. Dyn. pmid:18265023
Lecona E et al. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. 2008 Mol. Cell. Biol. pmid:18541673
Sasaki K et al. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. 2008 Cancer Sci. pmid:18271940
Moynihan AT et al. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. 2008 Am. J. Obstet. Gynecol. pmid:18455134
Brown CR et al. Global histone acetylation induces functional genomic reorganization at mammalian nuclear pore complexes. 2008 Genes Dev. pmid:18316479
Mackay CL et al. Sensitive, specific, and quantitative FTICR mass spectrometry of combinatorial post-translational modifications in intact histone H4. 2008 Anal. Chem. pmid:18457408
Fleury L et al. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells. 2008 Oncogene pmid:18317449
Muscolini M et al. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells. 2008 Mol. Cancer Ther. pmid:18566213
Fantini D et al. APE1/Ref-1 regulates PTEN expression mediated by Egr-1. 2008 Free Radic. Res. pmid:18324520
Bieliauskas AV and Pflum MK Isoform-selective histone deacetylase inhibitors. 2008 Chem Soc Rev pmid:18568166
Kang JH et al. CCAAT box is required for the induction of human thrombospondin-1 gene by trichostatin A. 2008 J. Cell. Biochem. pmid:18275041
Zhang Y et al. Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release. 2008 J. Biol. Chem. pmid:18596044
Oliva J et al. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. 2008 Exp. Mol. Pathol. pmid:18280469
Xu LN et al. Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines. 2008 World J. Gastroenterol. pmid:18442209
Nakamura C et al. Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells. 2008 Rheumatology (Oxford) pmid:18281366
Yu C et al. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. 2008 Neuro-oncology pmid:18445700
Yu WP et al. Induction of ID1 expression and apoptosis by the histone deacetylase inhibitor (trichostatin A) in human acute myeloid leukaemic cells. 2008 Cell Prolif. pmid:18211287
Jensen TJ et al. Epigenetic remodeling during arsenical-induced malignant transformation. 2008 Carcinogenesis pmid:18448484
Kikuno N et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. 2008 Int. J. Cancer pmid:18431742
van West P et al. Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. 2008 Microbiology (Reading, Engl.) pmid:18451057
Liu Z et al. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. 2008 Oncol. Rep. pmid:18575731
Plouffe D et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18579783
Sun Y et al. Modulation of transcription parameters in glucocorticoid receptor-mediated repression. 2008 Mol. Cell. Endocrinol. pmid:18583028
Lin YC et al. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. 2008 Cancer Res. pmid:18381445
Pandey SC et al. Brain chromatin remodeling: a novel mechanism of alcoholism. 2008 J. Neurosci. pmid:18385331
Rebbaa A et al. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent. 2008 Angiogenesis pmid:18386142
Henkens T et al. Differential effects of hydroxamate histone deacetylase inhibitors on cellular functionality and gap junctions in primary cultures of mitogen-stimulated hepatocytes. 2008 Toxicol. Lett. pmid:18358644
Wei Q et al. [Effect of trichostatin A on proliferation and interleukin-2 expression of mouse T cells in mixed lymphocyte culture]. 2008 Nan Fang Yi Ke Da Xue Xue Bao pmid:18359716
Hämäläinen M et al. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors. 2008 Pulm Pharmacol Ther pmid:17913526
Svechnikova I et al. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. 2008 Int. J. Oncol. pmid:18360709
Fontán-Lozano A et al. Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. 2008 Mol. Cell. Neurosci. pmid:18638560
Mukherjee P et al. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy. 2008 Bioorg. Med. Chem. pmid:18362073
Fabre C et al. A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts. 2008 Cell Cycle pmid:18641459
Pryzbylkowski P et al. Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. 2008 Breast Cancer Res. Treat. pmid:17891453
Brown SL et al. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. 2008 Radiat. Res. pmid:18363436
Kozikowski AP et al. Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. 2008 J. Med. Chem. pmid:18642892
Vrbova G Spinal muscular atrophy: motoneurone or muscle disease? 2008 Neuromuscul. Disord. pmid:18365338
Dow GS et al. Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors. 2008 Antimicrob. Agents Chemother. pmid:18644969
Iager AE et al. Trichostatin A improves histone acetylation in bovine somatic cell nuclear transfer early embryos. 2008 Cloning Stem Cells pmid:18419249
Liu PY et al. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. 2008 Mol. Cancer Res. pmid:18644983
Liu TC et al. Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects. 2008 Mol. Ther. pmid:18388912
Roy S et al. Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells. 2008 Mol. Cancer Ther. pmid:18645003
Hayakawa F et al. Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. 2008 J. Biol. Chem. pmid:18621739
Reilly CM et al. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. 2008 J. Autoimmun. pmid:18650065
Law AY et al. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. 2008 Exp. Cell Res. pmid:18652825
Bosisio D et al. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. 2008 J. Leukoc. Biol. pmid:18780875
Yang L et al. [Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro]. 2008 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:18718068
Zou XM et al. Gastric cancer cell lines induced by trichostatin A. 2008 World J. Gastroenterol. pmid:18720545
Carlisi D et al. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. 2008 Int. J. Oncol. pmid:18097557
Seo JS et al. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. 2008 Oncol. Rep. pmid:18097580
Yeh JR et al. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. 2008 Development pmid:18156164
Liu F et al. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. 2008 J. Mol. Cell. Cardiol. pmid:18926829
Gu Z et al. Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas. 2008 Genes Genet. Syst. pmid:18931460
Yoshioka H et al. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A. 2008 J. Biol. Chem. pmid:18801729
Wu Y and Guo SW Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. 2008 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17376583
Jin B et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. 2008 Hum. Mol. Genet. pmid:18029387
Gan Y et al. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells. 2008 Biochem. Biophys. Res. Commun. pmid:17996726
Lee EJ et al. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. 2008 Int. J. Oncol. pmid:18813790
Van Wagoner DR and Nattel S Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. 2008 J. Mol. Cell. Cardiol. pmid:18817781